
Magenta Medical Closes $55M Funding Round Led by OrbiMed
Magenta Medical notes the funding will further the company’s clinical programs in support of FDA approval for world’s smallest heart pump.
Florida / New York
Ph: 561.316.3330
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Magenta Medical notes the funding will further the company’s clinical programs in support of FDA approval for world’s smallest heart pump.
“Our goal is to make ear and hearing healthcare easily accessible to everybody, on a global scale” said Dr Krishan Ramdoo, Founder & CEO of TympaHealth. “Putting the right technology and support into the hands of more healthcare professionals and community providers is the best possible place to start. The Tympa Platform has proven its benefits at every point in the healthcare value chain and with our new funding, we can expand that value to new partners and markets.”
Ciliatech notes the funds will advance the development of their disruptive glaucoma implant CID and initiate clinical trials in Europe, paving the way for CE mark approval.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330